Only my opinion, but I think you are missing the ”primary point” here with any kind of financing (or dilution). The primary point is that the amount of shares attributable towards the dilution that some have been focusing on as a concern only amounts to 12,311,330 shares. Even better… such amounts to the Outstanding Shares (OS) being only 57,675,417 shares: http://ih.advfn.com/p.php?pid=nmona&article=68710810
I think that 100% of all penny stocks either had or will have at some point in time some kind of dilution. Depending on how such is managed/handled is what will determine if it should be considered toxic regardless to whoever the name of the person or company providing the financing. Over 90% of the names of the financiers might as well be synonymous too for inquiring minds. The name of the lender is not as near as important as the terms and the amount of shares attributable towards dilution.
No matter how the icing is prepared on the outside of a stock, almost all of them have something dilutive in the inside at one point or another. It’s the amount of toxicity that is important to understand. Anyone buying any penny stock should know and understand this or they shouldn't be buying penny stocks in the first place. The #1 reason why any stock exists within the market is to be able to dilute... or to better say it… to be able to use their shares as leverage to grow its operations. The dilution here is very minimal regardless to how anyone cares to try to twist such. From what I see, the company is being very careful with their dilution and have been for years.
The key is to figure out where is that balance for timing when such dilution from financing will cease to where it then trades clean and have a chance to achieve new highs from its previous bottom... based on where you got in at. Dilution is the reason why investors have a fair chance to get in at or near the bottom for making the decision to take the risk. I say this because a bottom for me might not be a bottom for you or vice versa. That's another long story in itself.
I challenge anyone here to go search through their own profile and pick their favorite two or three stocks that they either like or don’t like and ”compare and contrast” their share structures, along with any of the companies’ current and past dilutive situations, up against the EGYH share structure. Many, if not all, will see that their favorite stocks have more dilutive concerns than what exists here with EGYH. I already done such comparison within such peoples’ profiles.
I still stand by my belief in that being patient will bring huge rewards here with EGYH.
News 
Market Data 
Discover 
